Third-Generation Vaccines Take Center Stage in Battle Against COVID-19
Bio Law Blog
NOVEMBER 29, 2020
The biopharmaceutical industry is at the forefront of COVID-19 news due to major advances in vaccine development. Now, more than a year since the first case of COVID-19 and nearing a year since daily life has been upended by the pandemic, hopes for a return to normal rest largely on the effectiveness of mass vaccination against SARS-CoV-2, the virus that causes COVID-19.
75 
Let's personalize your content